1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Chronic Liver Diseases Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Chemotherapy Drugs 1.2.3 Targeted Therapy 1.2.4 Vaccines 1.2.5 Antiviral Drugs 1.2.6 Immunoglobulins 1.2.7 Corticosteroids 1.2.8 Others 1.3 Market by Application 1.3.1 Global Chronic Liver Diseases Therapeutics Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital Pharmacies 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Chronic Liver Diseases Therapeutics Market Perspective (2016-2027) 2.2 Chronic Liver Diseases Therapeutics Growth Trends by Regions 2.2.1 Chronic Liver Diseases Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Chronic Liver Diseases Therapeutics Historic Market Share by Regions (2016-2021) 2.2.3 Chronic Liver Diseases Therapeutics Forecasted Market Size by Regions (2022-2027) 2.3 Chronic Liver Diseases Therapeutics Industry Dynamic 2.3.1 Chronic Liver Diseases Therapeutics Market Trends 2.3.2 Chronic Liver Diseases Therapeutics Market Drivers 2.3.3 Chronic Liver Diseases Therapeutics Market Challenges 2.3.4 Chronic Liver Diseases Therapeutics Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Chronic Liver Diseases Therapeutics Players by Revenue 3.1.1 Global Top Chronic Liver Diseases Therapeutics Players by Revenue (2016-2021) 3.1.2 Global Chronic Liver Diseases Therapeutics Revenue Market Share by Players (2016-2021) 3.2 Global Chronic Liver Diseases Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Chronic Liver Diseases Therapeutics Revenue 3.4 Global Chronic Liver Diseases Therapeutics Market Concentration Ratio 3.4.1 Global Chronic Liver Diseases Therapeutics Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Chronic Liver Diseases Therapeutics Revenue in 2020 3.5 Chronic Liver Diseases Therapeutics Key Players Head office and Area Served 3.6 Key Players Chronic Liver Diseases Therapeutics Product Solution and Service 3.7 Date of Enter into Chronic Liver Diseases Therapeutics Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Chronic Liver Diseases Therapeutics Breakdown Data by Type 4.1 Global Chronic Liver Diseases Therapeutics Historic Market Size by Type (2016-2021) 4.2 Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Type (2022-2027) 5 Chronic Liver Diseases Therapeutics Breakdown Data by Application 5.1 Global Chronic Liver Diseases Therapeutics Historic Market Size by Application (2016-2021) 5.2 Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Chronic Liver Diseases Therapeutics Market Size (2016-2027) 6.2 North America Chronic Liver Diseases Therapeutics Market Size by Type 6.2.1 North America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) 6.2.2 North America Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) 6.2.3 North America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2027) 6.3 North America Chronic Liver Diseases Therapeutics Market Size by Application 6.3.1 North America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) 6.3.2 North America Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) 6.3.3 North America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2027) 6.4 North America Chronic Liver Diseases Therapeutics Market Size by Country 6.4.1 North America Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021) 6.4.2 North America Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Chronic Liver Diseases Therapeutics Market Size (2016-2027) 7.2 Europe Chronic Liver Diseases Therapeutics Market Size by Type 7.2.1 Europe Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) 7.2.2 Europe Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) 7.2.3 Europe Chronic Liver Diseases Therapeutics Market Size by Type (2016-2027) 7.3 Europe Chronic Liver Diseases Therapeutics Market Size by Application 7.3.1 Europe Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) 7.3.2 Europe Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) 7.3.3 Europe Chronic Liver Diseases Therapeutics Market Size by Application (2016-2027) 7.4 Europe Chronic Liver Diseases Therapeutics Market Size by Country 7.4.1 Europe Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021) 7.4.2 Europe Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size (2016-2027) 8.2 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type 8.2.1 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2016-2027) 8.3 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application 8.3.1 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2016-2027) 8.4 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region 8.4.1 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Chronic Liver Diseases Therapeutics Market Size (2016-2027) 9.2 Latin America Chronic Liver Diseases Therapeutics Market Size by Type 9.2.1 Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) 9.2.2 Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) 9.2.3 Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2027) 9.3 Latin America Chronic Liver Diseases Therapeutics Market Size by Application 9.3.1 Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) 9.3.2 Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) 9.3.3 Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2027) 9.4 Latin America Chronic Liver Diseases Therapeutics Market Size by Country 9.4.1 Latin America Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021) 9.4.2 Latin America Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size (2016-2027) 10.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type 10.2.1 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2016-2027) 10.3 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application 10.3.1 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2016-2027) 10.4 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country 10.4.1 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Astellas Pharma 11.1.1 Astellas Pharma Company Details 11.1.2 Astellas Pharma Business Overview 11.1.3 Astellas Pharma Chronic Liver Diseases Therapeutics Introduction 11.1.4 Astellas Pharma Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.1.5 Astellas Pharma Recent Development 11.2 Bristol-Myers Squibb 11.2.1 Bristol-Myers Squibb Company Details 11.2.2 Bristol-Myers Squibb Business Overview 11.2.3 Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Introduction 11.2.4 Bristol-Myers Squibb Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.2.5 Bristol-Myers Squibb Recent Development 11.3 Gilead Sciences 11.3.1 Gilead Sciences Company Details 11.3.2 Gilead Sciences Business Overview 11.3.3 Gilead Sciences Chronic Liver Diseases Therapeutics Introduction 11.3.4 Gilead Sciences Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.3.5 Gilead Sciences Recent Development 11.4 GlaxoSmithKline 11.4.1 GlaxoSmithKline Company Details 11.4.2 GlaxoSmithKline Business Overview 11.4.3 GlaxoSmithKline Chronic Liver Diseases Therapeutics Introduction 11.4.4 GlaxoSmithKline Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.4.5 GlaxoSmithKline Recent Development 11.5 F. Hoffmann-La Roche 11.5.1 F. Hoffmann-La Roche Company Details 11.5.2 F. Hoffmann-La Roche Business Overview 11.5.3 F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Introduction 11.5.4 F. Hoffmann-La Roche Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.5.5 F. Hoffmann-La Roche Recent Development 11.6 Merck 11.6.1 Merck Company Details 11.6.2 Merck Business Overview 11.6.3 Merck Chronic Liver Diseases Therapeutics Introduction 11.6.4 Merck Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.6.5 Merck Recent Development 11.7 Novartis 11.7.1 Novartis Company Details 11.7.2 Novartis Business Overview 11.7.3 Novartis Chronic Liver Diseases Therapeutics Introduction 11.7.4 Novartis Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.7.5 Novartis Recent Development 11.8 Sanofi 11.8.1 Sanofi Company Details 11.8.2 Sanofi Business Overview 11.8.3 Sanofi Chronic Liver Diseases Therapeutics Introduction 11.8.4 Sanofi Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.8.5 Sanofi Recent Development 11.9 Pfizer 11.9.1 Pfizer Company Details 11.9.2 Pfizer Business Overview 11.9.3 Pfizer Chronic Liver Diseases Therapeutics Introduction 11.9.4 Pfizer Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.9.5 Pfizer Recent Development 11.10 Takeda Pharmaceutical 11.10.1 Takeda Pharmaceutical Company Details 11.10.2 Takeda Pharmaceutical Business Overview 11.10.3 Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Introduction 11.10.4 Takeda Pharmaceutical Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.10.5 Takeda Pharmaceutical Recent Development 11.11 Bausch Health 11.11.1 Bausch Health Company Details 11.11.2 Bausch Health Business Overview 11.11.3 Bausch Health Chronic Liver Diseases Therapeutics Introduction 11.11.4 Bausch Health Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.11.5 Bausch Health Recent Development 11.12 Theratechnologies 11.12.1 Theratechnologies Company Details 11.12.2 Theratechnologies Business Overview 11.12.3 Theratechnologies Chronic Liver Diseases Therapeutics Introduction 11.12.4 Theratechnologies Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.12.5 Theratechnologies Recent Development 11.13 Alnylam Pharmaceuticals 11.13.1 Alnylam Pharmaceuticals Company Details 11.13.2 Alnylam Pharmaceuticals Business Overview 11.13.3 Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Introduction 11.13.4 Alnylam Pharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.13.5 Alnylam Pharmaceuticals Recent Development 11.14 Protagonist Therapeutics 11.14.1 Protagonist Therapeutics Company Details 11.14.2 Protagonist Therapeutics Business Overview 11.14.3 Protagonist Therapeutics Chronic Liver Diseases Therapeutics Introduction 11.14.4 Protagonist Therapeutics Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.14.5 Protagonist Therapeutics Recent Development 11.15 Dicerna Pharmaceuticals 11.15.1 Dicerna Pharmaceuticals Company Details 11.15.2 Dicerna Pharmaceuticals Business Overview 11.15.3 Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Introduction 11.15.4 Dicerna Pharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.15.5 Dicerna Pharmaceuticals Recent Development 11.16 Endo International 11.16.1 Endo International Company Details 11.16.2 Endo International Business Overview 11.16.3 Endo International Chronic Liver Diseases Therapeutics Introduction 11.16.4 Endo International Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.16.5 Endo International Recent Development 11.17 Provectus Biopharmaceuticals 11.17.1 Provectus Biopharmaceuticals Company Details 11.17.2 Provectus Biopharmaceuticals Business Overview 11.17.3 Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Introduction 11.17.4 Provectus Biopharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.17.5 Provectus Biopharmaceuticals Recent Development 11.18 MAX BioPharma 11.18.1 MAX BioPharma Company Details 11.18.2 MAX BioPharma Business Overview 11.18.3 MAX BioPharma Chronic Liver Diseases Therapeutics Introduction 11.18.4 MAX BioPharma Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) 11.18.5 MAX BioPharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Chronic Liver Diseases Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Chemotherapy Drugs Table 3. Key Players of Targeted Therapy Table 4. Key Players of Vaccines Table 5. Key Players of Antiviral Drugs Table 6. Key Players of Immunoglobulins Table 7. Key Players of Corticosteroids Table 8. Key Players of Others Table 9. Global Chronic Liver Diseases Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 10. Global Chronic Liver Diseases Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 11. Global Chronic Liver Diseases Therapeutics Market Size by Regions (2016-2021) & (US$ Million) Table 12. Global Chronic Liver Diseases Therapeutics Market Share by Regions (2016-2021) Table 13. Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 14. Global Chronic Liver Diseases Therapeutics Market Share by Regions (2022-2027) Table 15. Chronic Liver Diseases Therapeutics Market Trends Table 16. Chronic Liver Diseases Therapeutics Market Drivers Table 17. Chronic Liver Diseases Therapeutics Market Challenges Table 18. Chronic Liver Diseases Therapeutics Market Restraints Table 19. Global Chronic Liver Diseases Therapeutics Revenue by Players (2016-2021) & (US$ Million) Table 20. Global Chronic Liver Diseases Therapeutics Market Share by Players (2016-2021) Table 21. Global Top Chronic Liver Diseases Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Liver Diseases Therapeutics as of 2020) Table 22. Ranking of Global Top Chronic Liver Diseases Therapeutics Companies by Revenue (US$ Million) in 2020 Table 23. Global 5 Largest Players Market Share by Chronic Liver Diseases Therapeutics Revenue (CR5 and HHI) & (2016-2021) Table 24. Key Players Headquarters and Area Served Table 25. Key Players Chronic Liver Diseases Therapeutics Product Solution and Service Table 26. Date of Enter into Chronic Liver Diseases Therapeutics Market Table 27. Mergers & Acquisitions, Expansion Plans Table 28. Global Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 29. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Type (2016-2021) Table 30. Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million) Table 31. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million) Table 32. Global Chronic Liver Diseases Therapeutics Market Size Share by Application (2016-2021) & (US$ Million) Table 33. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Application (2016-2021) Table 34. Global Chronic Liver Diseases Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million) Table 35. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million) Table 36. North America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 37. North America Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 38. North America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 39. North America Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 40. North America Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 41. North America Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 42. Europe Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 43. Europe Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 44. Europe Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 45. Europe Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 46. Europe Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 47. Europe Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 48. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 49. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 50. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 51. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 52. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region (2016-2021) & (US$ Million) Table 53. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size by Region (2022-2027) & (US$ Million) Table 54. Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 55. Latin America Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 56. Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 57. Latin America Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 58. Latin America Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 59. Latin America Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 60. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2016-2021) (US$ Million) Table 61. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Type (2022-2027) & (US$ Million) Table 62. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2016-2021) (US$ Million) Table 63. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Application (2022-2027) & (US$ Million) Table 64. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country (2016-2021) & (US$ Million) Table 65. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size by Country (2022-2027) & (US$ Million) Table 66. Astellas Pharma Company Details Table 67. Astellas Pharma Business Overview Table 68. Astellas Pharma Chronic Liver Diseases Therapeutics Product Table 69. Astellas Pharma Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 70. Astellas Pharma Recent Development Table 71. Bristol-Myers Squibb Company Details Table 72. Bristol-Myers Squibb Business Overview Table 73. Bristol-Myers Squibb Chronic Liver Diseases Therapeutics Product Table 74. Bristol-Myers Squibb Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 75. Bristol-Myers Squibb Recent Development Table 76. Gilead Sciences Company Details Table 77. Gilead Sciences Business Overview Table 78. Gilead Sciences Chronic Liver Diseases Therapeutics Product Table 79. Gilead Sciences Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 80. Gilead Sciences Recent Development Table 81. GlaxoSmithKline Company Details Table 82. GlaxoSmithKline Business Overview Table 83. GlaxoSmithKline Chronic Liver Diseases Therapeutics Product Table 84. GlaxoSmithKline Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 85. GlaxoSmithKline Recent Development Table 86. F. Hoffmann-La Roche Company Details Table 87. F. Hoffmann-La Roche Business Overview Table 88. F. Hoffmann-La Roche Chronic Liver Diseases Therapeutics Product Table 89. F. Hoffmann-La Roche Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 90. F. Hoffmann-La Roche Recent Development Table 91. Merck Company Details Table 92. Merck Business Overview Table 93. Merck Chronic Liver Diseases Therapeutics Product Table 94. Merck Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 95. Merck Recent Development Table 96. Novartis Company Details Table 97. Novartis Business Overview Table 98. Novartis Chronic Liver Diseases Therapeutics Product Table 99. Novartis Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 100. Novartis Recent Development Table 101. Sanofi Company Details Table 102. Sanofi Business Overview Table 103. Sanofi Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 104. Sanofi Recent Development Table 105. Pfizer Company Details Table 106. Pfizer Business Overview Table 107. Pfizer Chronic Liver Diseases Therapeutics Product Table 108. Pfizer Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 109. Pfizer Recent Development Table 110. Takeda Pharmaceutical Company Details Table 111. Takeda Pharmaceutical Business Overview Table 112. Takeda Pharmaceutical Chronic Liver Diseases Therapeutics Product Table 113. Takeda Pharmaceutical Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 114. Takeda Pharmaceutical Recent Development Table 115. Bausch Health Company Details Table 116. Bausch Health Business Overview Table 117. Bausch Health Chronic Liver Diseases Therapeutics Product Table 118. Bausch Health Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 119. Bausch Health Recent Development Table 120. Theratechnologies Company Details Table 121. Theratechnologies Business Overview Table 122. Theratechnologies Chronic Liver Diseases Therapeutics Product Table 123. Theratechnologies Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 124. Theratechnologies Recent Development Table 125. Alnylam Pharmaceuticals Company Details Table 126. Alnylam Pharmaceuticals Business Overview Table 127. Alnylam Pharmaceuticals Chronic Liver Diseases Therapeutics Product Table 128. Alnylam Pharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 129. Alnylam Pharmaceuticals Recent Development Table 130. Protagonist Therapeutics Company Details Table 131. Protagonist Therapeutics Business Overview Table 132. Protagonist Therapeutics Chronic Liver Diseases Therapeutics Product Table 133. Protagonist Therapeutics Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 134. Protagonist Therapeutics Recent Development Table 135. Dicerna Pharmaceuticals Company Details Table 136. Dicerna Pharmaceuticals Business Overview Table 137. Dicerna Pharmaceuticals Chronic Liver Diseases Therapeutics Product Table 138. Dicerna Pharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 139. Dicerna Pharmaceuticals Recent Development Table 140. Endo International Company Details Table 141. Endo International Business Overview Table 142. Endo International Chronic Liver Diseases Therapeutics Product Table 143. Endo International Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 144. Endo International Recent Development Table 145. Provectus Biopharmaceuticals Company Details Table 146. Provectus Biopharmaceuticals Business Overview Table 147. Provectus Biopharmaceuticals Chronic Liver Diseases Therapeutics Product Table 148. Provectus Biopharmaceuticals Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 149. Provectus Biopharmaceuticals Recent Development Table 150. MAX BioPharma Company Details Table 151. MAX BioPharma Business Overview Table 152. MAX BioPharma Chronic Liver Diseases Therapeutics Product Table 153. MAX BioPharma Revenue in Chronic Liver Diseases Therapeutics Business (2016-2021) & (US$ Million) Table 154. MAX BioPharma Recent Development Table 155. Research Programs/Design for This Report Table 156. Key Data Information from Secondary Sources Table 157. Key Data Information from Primary Sources List of Figures Figure 1. Global Chronic Liver Diseases Therapeutics Market Share by Type: 2020 VS 2027 Figure 2. Chemotherapy Drugs Features Figure 3. Targeted Therapy Features Figure 4. Vaccines Features Figure 5. Antiviral Drugs Features Figure 6. Immunoglobulins Features Figure 7. Corticosteroids Features Figure 8. Others Features Figure 9. Global Chronic Liver Diseases Therapeutics Market Share by Application: 2020 VS 2027 Figure 10. Hospital Pharmacies Case Studies Figure 11. Retail Pharmacies Case Studies Figure 12. Online Pharmacies Case Studies Figure 13. Chronic Liver Diseases Therapeutics Report Years Considered Figure 14. Global Chronic Liver Diseases Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 15. Global Chronic Liver Diseases Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Chronic Liver Diseases Therapeutics Market Share by Regions: 2020 VS 2027 Figure 17. Global Chronic Liver Diseases Therapeutics Market Share by Regions (2022-2027) Figure 18. Global Chronic Liver Diseases Therapeutics Market Share by Players in 2020 Figure 19. Global Top Chronic Liver Diseases Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Liver Diseases Therapeutics as of 2020 Figure 20. The Top 10 and 5 Players Market Share by Chronic Liver Diseases Therapeutics Revenue in 2020 Figure 21. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Type (2016-2021) Figure 22. Global Chronic Liver Diseases Therapeutics Revenue Market Share by Type (2022-2027) Figure 23. North America Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. North America Chronic Liver Diseases Therapeutics Market Share by Type (2016-2027) Figure 25. North America Chronic Liver Diseases Therapeutics Market Share by Application (2016-2027) Figure 26. North America Chronic Liver Diseases Therapeutics Market Share by Country (2016-2027) Figure 27. United States Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Canada Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 29. Europe Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. Europe Chronic Liver Diseases Therapeutics Market Share by Type (2016-2027) Figure 31. Europe Chronic Liver Diseases Therapeutics Market Share by Application (2016-2027) Figure 32. Europe Chronic Liver Diseases Therapeutics Market Share by Country (2016-2027) Figure 33. Germany Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. France Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. U.K. Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Italy Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Russia Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Nordic Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 39. Asia-Pacific Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Asia-Pacific Chronic Liver Diseases Therapeutics Market Share by Type (2016-2027) Figure 41. Asia-Pacific Chronic Liver Diseases Therapeutics Market Share by Application (2016-2027) Figure 42. Asia-Pacific Chronic Liver Diseases Therapeutics Market Share by Region (2016-2027) Figure 43. China Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Japan Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. South Korea Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Southeast Asia Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. India Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Australia Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 49. Latin America Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Latin America Chronic Liver Diseases Therapeutics Market Share by Type (2016-2027) Figure 51. Latin America Chronic Liver Diseases Therapeutics Market Share by Application (2016-2027) Figure 52. Latin America Chronic Liver Diseases Therapeutics Market Share by Country (2016-2027) Figure 53. Mexico Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Brazil Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 55. Middle East & Africa Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Middle East & Africa Chronic Liver Diseases Therapeutics Market Share by Type (2016-2027) Figure 57. Middle East & Africa Chronic Liver Diseases Therapeutics Market Share by Application (2016-2027) Figure 58. Middle East & Africa Chronic Liver Diseases Therapeutics Market Share by Country (2016-2027) Figure 59. Turkey Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. Saudi Arabia Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 61. UAE Chronic Liver Diseases Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million) Figure 62. Astellas Pharma Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 64. Gilead Sciences Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 65. GlaxoSmithKline Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 66. F. Hoffmann-La Roche Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 67. Merck Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 68. Novartis Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 69. Sanofi Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 70. Pfizer Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 71. Takeda Pharmaceutical Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 72. Bausch Health Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 73. Theratechnologies Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 74. Alnylam Pharmaceuticals Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 75. Protagonist Therapeutics Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 76. Dicerna Pharmaceuticals Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 77. Endo International Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 78. Provectus Biopharmaceuticals Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 79. MAX BioPharma Revenue Growth Rate in Chronic Liver Diseases Therapeutics Business (2016-2021) Figure 80. Bottom-up and Top-down Approaches for This Report Figure 81. Data Triangulation Figure 82. Key Executives Interviewed

Astellas Pharma Bristol-Myers Squibb Gilead Sciences GlaxoSmithKline F. Hoffmann-La Roche Merck Novartis Sanofi Pfizer Takeda Pharmaceutical Bausch Health Theratechnologies Alnylam Pharmaceuticals Protagonist Therapeutics Dicerna Pharmaceuticals Endo International Provectus Biopharmaceuticals MAX BioPharma